Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Icos begins phase II multiple-dose trial in multiple sclerosis patients

July 22, 1998

Spotlight on sigma-receptors as a target for intervention in CNS disorders

July 22, 1998

Benzodiazepine omega3 receptor ligands with anxiolytic, anticonvulsant and antiarthritic effects

July 22, 1998

New indication explored for established anticonvulsant

July 21, 1998

EEG analysis reveals the atypical antipsychotic profile of OPC-14597

July 21, 1998

SIB-1553A goes head-to-head with established cognition-enhancing drugs

July 21, 1998

Hypnotic effects of the benzodiazepine receptor ligand SX-3228 in rats

July 21, 1998

Restless legs syndrome: description and treatment options

July 21, 1998

Joint development agreement for Hyanalgese-D announced by Hyal

July 21, 1998

PNU-109291, a selective 5-HT1D agonist and potent antimigraine agent

July 20, 1998

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...